BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 1422487)

  • 1. Remission of Psychosis in Treatment-Resistant Schizophrenia following Bone Marrow Transplantation: A Case Report.
    Miyaoka T; Wake R; Hashioka S; Hayashida M; Oh-Nishi A; Azis IA; Izuhara M; Tsuchie K; Araki T; Arauchi R; Abdullah RA; Horiguchi J
    Front Psychiatry; 2017; 8():174. PubMed ID: 28983259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic burden associated with acute myeloid leukemia treatment.
    Zeidan AM; Mahmoud D; Kucmin-Bemelmans IT; Alleman CJ; Hensen M; Skikne B; Smith BD
    Expert Rev Hematol; 2016 Jan; 9(1):79-89. PubMed ID: 26568358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness and quality-of-life assessment of GM-CSF as an adjunct to intensive remission induction chemotherapy in elderly patients with acute myeloid leukemia.
    Uyl-de Groot CA; Löwenberg B; Vellenga E; Suciu S; Willemze R; Rutten FF
    Br J Haematol; 1998 Mar; 100(4):629-36. PubMed ID: 9531327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness and clinical outcomes of double versus single cord blood transplantation in adults with acute leukemia in France.
    Labopin M; Ruggeri A; Gorin NC; Gluckman E; Blaise D; Mannone L; Milpied N; Yakoub-Agha I; Deconinck E; Michallet M; Fegueux N; Socié G; Nguyen S; Cahn JY; de Revel T; Garnier F; Faucher C; Taright N; Kenzey C; Volt F; Bertrand D; Mohty M; Rocha V;
    Haematologica; 2014 Mar; 99(3):535-40. PubMed ID: 24143000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of lowering the costs of stem cell transplantation in developing countries.
    Barr RD
    Int J Hematol; 2002 Aug; 76 Suppl 1():365-7. PubMed ID: 12430883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costs of peripheral blood progenitor cell transplantation using whole blood mobilised by filgrastim as compared with autologous bone marrow transplantation in non-Hodgkin's lymphoma.
    Uyl-de Groot CA; Ossenkoppele GJ; Buijt I; Huijgens PC
    Pharmacoeconomics; 1999 Mar; 15(3):305-11. PubMed ID: 10537437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of lenograstim on the cost of autologous bone marrow transplantation. A preliminary communication.
    Brice P; Godin S; Libert O; Marolleau JP; Makki J; Extra JM; Faure P; Gisselbrecht C
    Pharmacoeconomics; 1995 Mar; 7(3):238-41. PubMed ID: 10155313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alglucerase. A pharmacoeconomic appraisal of its use in the treatment of Gaucher's disease.
    Whittington R; Goa KL
    Pharmacoeconomics; 1995 Jan; 7(1):63-90. PubMed ID: 10155294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idarubicin: a pharmacoeconomic evaluation of its use in adult patients with acute myeloid leukaemia.
    Whittington R; Goa KL
    Pharmacoeconomics; 1993 Oct; 4(4):287-307. PubMed ID: 10146918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcome following autologous and allogeneic blood and marrow transplantation for relapsed diffuse large-cell non-Hodgkin's lymphoma.
    Aksentijevich I; Jones RJ; Ambinder RF; Garrett-Mayer E; Flinn IW
    Biol Blood Marrow Transplant; 2006 Sep; 12(9):965-72. PubMed ID: 16920563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic burden of acute myeloid leukemia: a literature review.
    Redaelli A; Botteman MF; Stephens JM; Brandt S; Pashos CL
    Cancer Treat Rev; 2004 May; 30(3):237-47. PubMed ID: 15059647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow transplantation for acute non-lymphoblastic leukemia.
    Ljungman P; Gahrton G
    Leuk Lymphoma; 1992 May; 7(1-2):7-14. PubMed ID: 1472935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative cost of allogeneic or autologous bone marrow transplantation and chemotherapy in patients with acute myeloid leukaemia in first remission.
    Dufoir T; Saux MC; Terraza B; Marit G; Guessard S; Foulon G; Reiffers J
    Bone Marrow Transplant; 1992 Oct; 10(4):323-9. PubMed ID: 1422487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy.
    Ortega JJ; Díaz de Heredia C; Olivé T; Bastida P; Llort A; Armadans L; Torrabadella M; Massuet L
    Haematologica; 2003 Mar; 88(3):290-9. PubMed ID: 12651268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic or autologous bone marrow transplantation for acute lymphoblastic leukemia in first complete remission.
    Blaise D; Gaspard MH; Stoppa AM; Michel G; Gastaut JA; Lepeu G; Tubiana N; Blanc AP; Rossi JF; Novakovitch G
    Bone Marrow Transplant; 1990 Jan; 5(1):7-12. PubMed ID: 2404531
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.